Can you buy Owkin stock?

As Owkin is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company likeOwkin, you must be an accredited investor . If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Owkin stock?

To invest in a private company like Owkin through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process . 1. Create a free account to access Forge’s marketplace. 2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies. 3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Owkin stock?

Yes, you may be able to sell your Owkin stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Owkin stock?

If you hold private company shares of Owkin - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Owkin stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is Owkin a public company?

No, Owkin is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Owkin’s stock price?

Owkin is a privately held company and therefore does not have a public stock price. However, you may access Owkin’s private market stock price with Forge Data .

What is Owkin’s stock ticker symbol?

Owkin does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Invest and Sell Owkin Stock

Sifted 06/26/2023

Pigment, Payfit and Owkin-backer Frst has closed €72m of third fund

Paris-based VC firm Frst has closed €72m of its third fund, with investors including the European Investment Fund, Bpifrance, Axa Venture Partners, Isomer and Mubadala. The firm plans to invest the capital over four years into 30 seed-stage companies across various sectors, with investments ranging between €1m-3m. Frst aims to close the fund at €100m and is seeking more sovereign wealth funds, fund-of-funds and asset managers to invest.

outsourcing-pharma.com 06/08/2023

Owkin invests $50M in spatial omics project that will 'revolutionize cancer research'

Owkin, an AI biotech company, has invested $50 million in a project using spatial omics to revolutionize cancer research. The project, named MOSAIC, will be conducted in collaboration with Nanostring Technologies and several leading cancer research institutions. Spatial omics allows researchers to examine tumors at near single-cell resolution, providing a detailed map of molecular interactions. The project aims to unlock the next wave of treatments for difficult-to-treat cancers.

Inside Precision Medicine 06/02/2023

MOSAIC Brings Big Guns to Spatial Genomics in Oncology

The Multi Omic Spatial Atlas in Cancer (MOSAIC) project, a collaboration involving several leading cancer research institutes, AI biotech pioneer Owkin, and spatial omics specialists NanoString, will mine 7,000 patient tumor samples for new biomarkers and therapeutics. Owkin is investing $50 million in the project, which aims to leverage spatial omics and AI to revolutionize oncology research and treatment.

Tech.eu 03/30/2023

French AI biotech unicorn Owkin has launched a €33 million AI-powered precision medicine project for cancer diagnosis and treatment

Owkin, a French AI biotech company, has launched a €33 million AI-powered precision medicine project for cancer diagnosis and treatment. The project, named PortrAIt, is backed by the French Government and will involve collaboration with France's top research hospitals and tech firms to develop at least 15 AI diagnostic tools. The five-year project aims to establish its platform within one year and deploy new AI-based patient diagnostics in hospitals within four years.

Owkin Stock

Register To Buy and Sell Shares

Enterprise Value

Access Owkin’s valuation and stock price.

Owkin investors also invested in these private companies

Team

Management Team

Board Members

Owkin stock FAQs